Trial lecture and disputation October 27-28th
Kristine Gulliksrud
Siv. ing. Kristine Gulliksrud from Einar Rofstad's group at the Department of Radiation Biology at the Institute for Cancer Research will give her trial lectures on Thursday October 27th. The lecture over the subject of her own choice - "Assessment of tumor pH by magnetic resonance spectroscopy and imaging" starts at 14:15. The given subject is "Therapeutic approaches for dealing with the hypoxia problem", and this lecture begins at 15:15. Both trial lectures take place in the Auditorium in the Research Therapy Building at the OUS-Radiumhospitalet, Montebello. She will defend her PhD thesis - entitled "DCE-MRI in assessment of the microenvironment and aggressiveness of human tumor xenografts" the following day, on Friday October 28th at 10:15. The disputation takes place in the "Lille Fysiske auditorium, Fysikkbygningen" at the University of Oslo.
From major journals, first or last author from the Institute for Cancer Research
Alampi MM, Kozlíková M, Mariangeli M, Civita S, Delcanale P, Mussini A, Diaspro A, Bianchini P, Weyergang A, Skarpen E, Berg K, Viappiani C, Abbruzzetti S, Selbo PK(2025) Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab Biomed Pharmacother, 191, 118550(in press) DOI 10.1016/j.biopha.2025.118550, PubMed 40946581
Eggebø MS, Heinzelbecker J, Palashati H, Chandler N, Tran TT, Li Y, Yang W, Laos M, Blaas I, Rustad EH, Bollineni RC, Delic-Sarac M, Lund-Johansen F, Nielsen MM, Olweus J(2025) TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors Nat Immunol(in press) DOI 10.1038/s41590-025-02252-1, PubMed 40866620
Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA(2025) Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy Mol Oncol(in press) DOI 10.1002/1878-0261.70117, PubMed 40852937
Nie X, Sun Y, van Dijk DPJ, Deng M, Brecheisen R, Wang Z, Xia Q, Olde Damink SMW, Rensen SS(2025) Loss of Skeletal Muscle Mass Is Associated With Reduced Cytotoxic T Cell Abundance and Poor Survival in Advanced Lung Cancer J Cachexia Sarcopenia Muscle, 16(5), e70063 DOI 10.1002/jcsm.70063, PubMed 40931431
Alampi MM, Kozlíková M, Mariangeli M, Civita S, Delcanale P, Mussini A, Diaspro A, Bianchini P, Weyergang A, Skarpen E, Berg K, Viappiani C, Abbruzzetti S, Selbo PK(2025) Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab Biomed Pharmacother, 191, 118550(in press) DOI 10.1016/j.biopha.2025.118550, PubMed 40946581
Ølnes ÅS, Teigen M, Laerdahl JK, Leren TP, Strøm TB, Bjune K(2025) Correction: Variants in the CETP gene affect levels of HDL cholesterol by reducing the amount, and not the specific lipid transfer activity, of secreted CETP PLoS One, 20(9), e0332400 DOI 10.1371/journal.pone.0332400, PubMed 40938802